Galmed Pharmaceuticals(GLMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GLMD Galmed Pharmaceuticals

Pre-Mkt 08-12 06:02:09 EDT

0.5569

-0.0362

-6.10%

盘前0.5569

+0.00000.00%

04:22 EDT

High0.5750	Low0.5501	Vol29.52K
Open0.5701	D1 Closing0.5931	Amplitude4.20%
Mkt Cap4.60M	Tradable Cap4.48M	Total Shares8.26M
T/O16.70K	T/O Rate0.37%	Tradable Shares8.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GLMD","market":"US","secType":"STK","nameCN":"Galmed Pharmaceuticals","latestPrice":0.5569,"timestamp":1786478400000,"preClose":0.5931,"halted":0,"volume":29515,"hourTrading":{"tag":"盘前","latestPrice":0.5569,"preClose":0.5569,"latestTime":"04:22 EDT","volume":1,"amount":0.5569,"timestamp":1786522944574,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06103523857696849,"floatShares":8049700,"shares":8263000,"eps":-2.017511,"marketStatus":"Pre-Mkt","change":-0.0362,"latestTime":"08-12 06:02:09 EDT","open":0.5701,"high":0.575,"low":0.5501,"amount":16704,"amplitude":0.041983,"askPrice":0.6513,"askSize":100,"bidPrice":0.4933,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.017511,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786541400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1394683200000,"exchange":"NASDAQ","adjPreClose":0.5569,"preHourTrading":{"tag":"盘前","latestPrice":0.5569,"preClose":0.5569,"latestTime":"04:22 EDT","volume":1,"amount":0.5569,"timestamp":1786522944574,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.5569,"preClose":0.5569,"latestTime":"16:57 EDT","volume":1,"amount":0.568,"timestamp":1786481843088,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2470214540214049,"impliedVol":0.7031,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GLMD","defaultTab":"news","newsList":[{"id":"2656391566","title":"Galmed Pharmaceuticals Wins Nasdaq Extension to Regain $1 Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391566?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:28","pubTimestamp":1785529694,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals ( ($GLMD) ) has shared an announcement. On July 30, 2026, Galmed Pharmaceuticals reported it had received a notice from Nasd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-wins-nasdaq-extension-to-regain-1-bid-price-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-wins-nasdaq-extension-to-regain-1-bid-price-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","LCLG","NQmain","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655110118","title":"Galmed Pharmaceuticals: as a Result of Termination, All Rights to Licensed Technology Will Revert to Yissum","url":"https://stock-news.laohu8.com/highlight/detail?id=2655110118","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655110118?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:53","pubTimestamp":1785358409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V25X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655110038","title":"Galmed Pharmaceuticals: Co's Unit's Obligation to Fund Ongoing Patent Expenses Relating to Licensed Patents Will Cease Effective July 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2655110038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655110038?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:53","pubTimestamp":1785358409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V25X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655048811","title":"Galmed Pharmaceuticals: Co's Unit & Yissum Entered into Mutual Termination Letter to Terminate License Agreement, Dated June 28, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2655048811","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655048811?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:53","pubTimestamp":1785358409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V25X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654644009","title":"Galmed’s Aramchol ODF formulation shows positive results in Parkinson’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2654644009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654644009?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:16","pubTimestamp":1785237370,"startTime":"0","endTime":"0","summary":"Galmed (GLMD) announced continued advancement of Aramchol as a potential disease-modifying therapy for Parkinson’s disease, or PD, reporting signif...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galmeds-aramchol-odf-formulation-shows-positive-results-in-parkinsons-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galmeds-aramchol-odf-formulation-shows-positive-results-in-parkinsons-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654900696","title":"Galmed Says Aramchol Oral Film Boosts Bioavailability 150%, CNS Exposure 300% in Parkinson’s Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2654900696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654900696?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:02","pubTimestamp":1785236543,"startTime":"0","endTime":"0","summary":"Galmed says Aramchol oral film boosts bioavailability 150%, CNS exposure 300% in Parkinson’s programGalmed advanced Aramchol for Parkinson’s disease with an orally dispersible film formulation designe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLbNywn8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652792406","title":"Galmed Pharmaceuticals Unveils Cardiac-Targeted Aramchol LNP Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2652792406","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652792406?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:47","pubTimestamp":1784278078,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals ( ($GLMD) ) has provided an announcement. On July 16, 2026, Galmed Pharmaceuticals reported a breakthrough lipid nanoparticl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-unveils-cardiac-targeted-aramchol-lnp-breakthrough?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-unveils-cardiac-targeted-aramchol-lnp-breakthrough?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144950","title":"Galmed Partners with Barcode Nanotech on Heart-targeted Aramchol LNP Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144950","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144950?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:31","pubTimestamp":1784201484,"startTime":"0","endTime":"0","summary":"Galmed partners with Barcode Nanotech on heart-targeted Aramchol LNP formulationGalmed entered a collaboration with Barcode Nanotech to develop a cardiac-targeted lipid nanoparticle formulation of its","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL4ztmff:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651044934","title":"Galmed Announces the Breakthrough Development of Novel Lnp Cardiac Targeted Formulation of Its Scd1 Inhibitor, Aramchol","url":"https://stock-news.laohu8.com/highlight/detail?id=2651044934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651044934?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:30","pubTimestamp":1784201410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650391671","title":"Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2650391671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650391671?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:48","pubTimestamp":1783543703,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals ( ($GLMD) ) has issued an announcement. Galmed Pharmaceuticals filed a Form 6-K in early July 2026, providing unaudited cond...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-reports-wider-q1-2026-loss-amid-higher-rd-spending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-reports-wider-q1-2026-loss-amid-higher-rd-spending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650591524","title":"Galmed Pharmaceuticals Buys Colospan in Deal Valued up to $5.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2650591524","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650591524?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:17","pubTimestamp":1783541852,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals buys Colospan in deal valued up to $5.3 millionGalmed Pharmaceuticals agreed to buy Colospan, making the business a wholly owned subsidiary upon closing on June 22, 2026.Conside","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL9hMMpH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645078838","title":"Galmed Pharmaceuticals Completes Acquisition of Colospan Under Restructured Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2645078838","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645078838?lang=en_us&edition=fundamental","pubTime":"2026-06-22 21:55","pubTimestamp":1782136522,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals (GLMD) said Monday it completed its acquisition of Colospan under a restructured deal aimed at diminishing the dilutive event on its shareholders.Instead of issuing $2 million i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645402489","title":"BRIEF-Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms For Colospan Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2645402489","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645402489?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:51","pubTimestamp":1782129088,"startTime":"0","endTime":"0","summary":"BRIEF-Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms For Colospan Ltd.June 22 (Reuters) - Galmed Pharmaceuticals Ltd GLMD.O:GALMED PHARMACEUTICALS LTD. ANNOUNCES RESTRUCTURED ACQ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA5VJCTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645299700","title":"Galmed restructures Colospan deal terms, swaps $2 million share payment for earnout and extra cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2645299700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645299700?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:01","pubTimestamp":1782126117,"startTime":"0","endTime":"0","summary":"Galmed completed the acquisition of Colospan, making the medical device developer a wholly owned subsidiary.Reworked consideration replaced a planned USD 2 million share issuance with an extra USD 800,000 cash payment.The remaining value shifted to a capped USD 2 million earnout starting in Q3 2027, based on CG-100 net sales tiers of 7% and 9%.Earnout can accelerate on a strategic transaction involving the acquired business or IP, or if Galmed raises at least USD 17.5 million in equity financings.Deal adds CG-100, a CE-marked colorectal surgery device in the EU/Israel, positioning Galmed for earlier revenue generation from 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content us","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL2LNdZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029957","title":"Galmed Pharmaceuticals - Increases Cash Payment by $800K, Restructures $2 Mln Earnout Starting Q3 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029957?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA5VJCTX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029642","title":"Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029642?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA5VJCTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642420146","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (AUTL), Galmed Pharmaceuticals (GLMD) and Oculis Holding (OCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642420146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642420146?lang=en_us&edition=fundamental","pubTime":"2026-06-11 00:30","pubTimestamp":1781109011,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Autolus Therapeutics (AUTL), Galmed Pharmaceutical...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-autolus-therapeutics-autl-galmed-pharmaceuticals-glmd-and-oculis-holding-ocs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-autolus-therapeutics-autl-galmed-pharmaceuticals-glmd-and-oculis-holding-ocs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AUTL","GLMD","LU0029874061.USD","BK4588","HCSG","LABU","BK4585","BK4137","OCS","LU0128526141.USD","BK4007","XLV","XBI","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641448234","title":"Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2641448234","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641448234?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:47","pubTimestamp":1780922877,"startTime":"0","endTime":"0","summary":"An announcement from Galmed Pharmaceuticals ( ($GLMD) ) is now available. On June 8, 2026, Galmed Pharmaceuticals signed a share purchase agreement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-to-acquire-colospan-and-commit-6-million-to-european-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-to-acquire-colospan-and-commit-6-million-to-european-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641481477","title":"Galmed Pharmaceuticals - Colospan Shareholders to Receive $2.5 Mln Cash and $2 Mln in Galmed Shares at Closing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641481477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641481477?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:11","pubTimestamp":1780920672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUABV6B3T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641474481","title":"Galmed Pharmaceuticals - Plans $6 Mln Investment to Launch Colospan Device in Europe During H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641474481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641474481?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:11","pubTimestamp":1780920672,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUABV6B3T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.galmedpharma.com","stockEarnings":[{"period":"1week","weight":-0.0322},{"period":"1month","weight":-0.0055},{"period":"3month","weight":-0.0645},{"period":"6month","weight":-0.0856},{"period":"1year","weight":-0.6159},{"period":"ytd","weight":-0.258}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0207},{"period":"3month","weight":0.0381},{"period":"6month","weight":0.1311},{"period":"1year","weight":0.2117},{"period":"ytd","weight":0.13}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.024694},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.055438},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083341},{"month":4,"riseRate":0.538462,"avgChangeRate":-0.000255},{"month":5,"riseRate":0.461538,"avgChangeRate":-0.058128},{"month":6,"riseRate":0.692308,"avgChangeRate":0.128295},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.078327},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.061594},{"month":9,"riseRate":0.5,"avgChangeRate":0.034812},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.138105},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.048693},{"month":12,"riseRate":0.416667,"avgChangeRate":0.037621}],"exchange":"NASDAQ","name":"Galmed Pharmaceuticals","nameEN":"Galmed Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galmed Pharmaceuticals(GLMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Galmed Pharmaceuticals(GLMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Galmed Pharmaceuticals,GLMD,Galmed Pharmaceuticals股票,Galmed Pharmaceuticals股票老虎,Galmed Pharmaceuticals股票老虎国际,Galmed Pharmaceuticals行情,Galmed Pharmaceuticals股票行情,Galmed Pharmaceuticals股价,Galmed Pharmaceuticals股市,Galmed Pharmaceuticals股票价格,Galmed Pharmaceuticals股票交易,Galmed Pharmaceuticals股票购买,Galmed Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galmed Pharmaceuticals(GLMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Galmed Pharmaceuticals(GLMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}